Advanced search
Start date

Evaluation of estrogenic compounds in mitochondrial dysfunction and cellular metabolism in a tauopathy cell model

Grant number: 21/11960-1
Support type:Scholarships in Brazil - Scientific Initiation
Effective date (Start): November 01, 2021
Effective date (End): October 31, 2022
Field of knowledge:Biological Sciences - Pharmacology - Neuropsychopharmacology
Principal researcher:Rodrigo Portes Ureshino
Grantee:Arthur Luiz Miranda Nicastro
Home Institution: Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF). Universidade Federal de São Paulo (UNIFESP). Campus Diadema. Diadema , SP, Brazil
Associated research grant:16/20796-2 - Study of estrogen receptors mediated autophagy against tau toxicity in cell and zebrafish models, AP.JP


Tauopathies comprise a group of neurodegenerative diseases characterized by the presence of tau protein aggregates, in which Alzheimer's Disease is the most prevalent and occurs more frequently in women. In this context, recent studies have demonstrated the neuroprotective role of estrogens and their antioxidant effect in models of oxidative stress, however, the action of estrogen analogs and aromatase inhibitors in mitochondrial dysfunction that occurs in neurodegenerative diseases such as tauopathies has not been fully elucidated. Our group has screened a library of compounds that act on nuclear and membrane estrogen receptors, analyzing their potential to reduce the tau protein in a model of tauopathy, and 5 compounds were selected. Thus, this project aims to evaluate the action of these compounds and 17²-estradiol on mitochondrial bioenergetics in SH-SY5Y cells with overexpression of the tau 0N4R isoform (wild type or mutated P301L), by measuring two parameters: ATP and cAMP production. For this, measurements of ATP and cAMP production will be performed by fluorimetry methodology. Furthermore, the effects of estrogenic compounds on mitochondrial morphology will be observed by confocal microscopy. Thus, the evaluation of estrogenic compounds in mitochondrial dysfunction may provide important information to investigate a drug with potential use for neurodegenerative diseases, such as Alzheimer's disease. (AU)

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items

Please report errors in scientific publications list by writing to: